DDD

3D Systems Corporation outlook has improved due to a demand recovery in dental, manufacturing CapEx, and defense. While Q3 guidance is soft, 3D Systems' core business is likely to continue accelerating in coming quarters. Cost-cutting efforts and operating leverage should see 3D Systems' approach breakeven in coming quarters. Long-term profitability remains a key uncertainty though.

3D Systems NYSE: DDD reported second-quarter revenue growth, a sharp increase in printer sales and improved adjusted EBITDA as demand strengthened across its targeted healthcare and industrial markets. The company also disclosed that President and Chief Executive Officer Jeffrey Graves plans to conclude his service as CEO following a succession process that has recently begun.

3D Systems Corporation (DDD) Q2 2026 Earnings Call Transcript

3D Systems beat Q2 estimates as strong metal and polymer printer sales lifted healthcare growth despite margin pressure.

ROCK HILL, S.C., Aug. 04, 2026 (GLOBE NEWSWIRE) -- 3D Systems (NYSE: DDD), a leading provider of additive manufacturing solutions, today announced a leadership transition plan in which Dr. Jeffrey Graves will step down as President and Chief Executive Officer and retire from the Board of Directors.

ROCK HILL, S.C., Aug. 03, 2026 (GLOBE NEWSWIRE) -- 3D Systems Corporation (NYSE:DDD) announced today its financial results for the second quarter ended June 30, 2026.

GAMI manufacturing license advances NAMI's role in defense localization and supports critical infrastructure resilience in the Kingdom ROCK HILL, S.C., July 29, 2026 (GLOBE NEWSWIRE) -- 3D Systems (NYSE:DDD) today announced that the National Additive Manufacturing and Innovation Company (NAMI) has been granted a Military Manufacturing License by the General Authority for Military Industries (GAMI) of Saudi Arabia.

ROCK HILL, S.C., July 28, 2026 (GLOBE NEWSWIRE) -- Today, 3D Systems (NYSE: DDD) announced its role in enabling the Defense Health Agency (DHA) and the Walter Reed National Military Medical Center's 3D Medical Applications Center (3D MAC) to achieve U.S. Food and Drug Administration (FDA) premarket clearance for the 3D MAC Titanium Cranial Plate (TCP) System, the first-ever FDA-cleared implant granted to a point-of-care institution. 3D MAC's patient-specific Titanium Cranial Plate (TCP) will be used to treat U.S. active duty personnel and war fighters suffering from traumatic head injuries around the world.

ROCK HILL, S.C., July 27, 2026 (GLOBE NEWSWIRE) -- Today, 3D Systems (NYSE: DDD) announced that Elmet Technologies, a wholly owned subsidiary of The Elmet Group (Nasdaq: ELMT) (“Elmet”), is deploying the DMP Flex 350 Triple metal additive manufacturing machine (laser powder bed fusion) for the rapid production of advanced aerospace parts for hypersonic vehicles. Utilizing a high-performance C103 material, the Elmet team expects to rapidly qualify and certify the system to begin production in 2026.

ROCK HILL, S.C., July 23, 2026 (GLOBE NEWSWIRE) -- 3D Systems  (NYSE: DDD) announced today it will release its financial results for the second quarter 2026 after the U.S. stock market closes on Monday, August 3, 2026. The company will hold a conference call and simultaneous webcast to discuss these financial results on Tuesday, August 4, 2026, at 8:30 a.m. Eastern Time.